Wednesday, November 20, 2024 9:37:05 AM
I forgot to mention this possibility in my last post.
We know something is brewing.
Now let me make this point. Not all is lost if the company decides to discontinue the current MJ business model.
Remember, take this in account. If all else fails, we have what is left a great Shell Company and a very attractive share structure that we have ownership and ripe for R/M candidate.
If this is the case. The element left standing is a Shell Company without debt and no business model. As I mentioned yesterday that preferred wants out and this may denote that the company will become a Shell Company looking for a marriage- new private business model. This will be the only value left that puts current shareholders in a very promising position.
Just a thought, but a very valuable one that I know many of you have been in awaiting Shell opportunities.
Not all is lost if this is the remaining option. One reason why I continue to hold and bought into this yesterday for such an outcome.
Public companies that are shell Companies are in high demand and offer unique opportunities for holders.
Have a good day
varok
We know something is brewing.
Now let me make this point. Not all is lost if the company decides to discontinue the current MJ business model.
Remember, take this in account. If all else fails, we have what is left a great Shell Company and a very attractive share structure that we have ownership and ripe for R/M candidate.
If this is the case. The element left standing is a Shell Company without debt and no business model. As I mentioned yesterday that preferred wants out and this may denote that the company will become a Shell Company looking for a marriage- new private business model. This will be the only value left that puts current shareholders in a very promising position.
Just a thought, but a very valuable one that I know many of you have been in awaiting Shell opportunities.
Not all is lost if this is the remaining option. One reason why I continue to hold and bought into this yesterday for such an outcome.
Public companies that are shell Companies are in high demand and offer unique opportunities for holders.
Have a good day
varok
Recent BLEG News
- Branded Legacy, Inc. (OTC: BLEG) Successfully Negotiates Retirement of Four Additional Convertible Notes, Preventing Potential Dilution of Hundreds of Millions of Shares • InvestorsHub NewsWire • 02/04/2026 02:07:00 PM
- Branded Legacy, Inc. (OTC: BLEG) Successfully Negotiates Retirement of Four Additional Convertible Notes, Preventing Potential Dilution of Hundreds of Millions of Shares • GlobeNewswire Inc. • 02/04/2026 02:07:00 PM
- Branded Legacy, Inc. Announces Successful Retirement of Legacy Convertible Debt as New Management Focuses on Balance Sheet Optimization and OTC Yield Sign Removal • InvestorsHub NewsWire • 12/29/2025 01:30:00 PM
- Branded Legacy, Inc. Announces Successful Retirement of Legacy Convertible Debt as New Management Focuses on Balance Sheet Optimization and OTC Yield Sign Removal • GlobeNewswire Inc. • 12/29/2025 01:30:00 PM
- Branded Legacy, Inc. Announces Complete Management Overhaul and Strategic Reset Under New Leadership • GlobeNewswire Inc. • 12/10/2025 02:17:29 PM
- Branded Legacy, Inc. Announces Complete Management Overhaul and Strategic Reset Under New Leadership • InvestorsHub NewsWire • 12/10/2025 02:00:00 PM
- Branded Legacy Announces Strong Revenues from Newly Acquired Pau Hana Subsidiary • GlobeNewswire Inc. • 11/25/2025 03:38:40 PM
- Branded Legacy Announces Strong Revenues from Newly Acquired Pau Hana Subsidiary • InvestorsHub NewsWire • 11/25/2025 03:11:49 PM
- Branded Legacy, Inc. Advances Revolutionary Intranasal Drug Delivery with Unitary Device Mold Development • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Branded Legacy, Inc. Advances Revolutionary Intranasal Drug Delivery with Unitary Device Mold Development • InvestorsHub NewsWire • 10/27/2025 12:30:00 PM
- Branded Legacy, Inc. (OTC: BLEG) Advances Life-Saving Innovation with FDA Pre-ANDA Briefing for Revolutionary Intranasal Naloxone Spray • GlobeNewswire Inc. • 10/22/2025 03:17:40 PM
- Branded Legacy, Inc. (OTC: BLEG) Advances Life-Saving Innovation with FDA Pre-ANDA Briefing for Revolutionary Intranasal Naloxone Spray • InvestorsHub NewsWire • 10/22/2025 02:56:16 PM
- Branded Legacy, Inc. Announces Provisional Patent Filing by BioLegacy for Disruptive Air-Driven Intranasal Platform Targeting Multi-Billion-Dollar Global Therapeutics Market • InvestorsHub NewsWire • 09/30/2025 12:30:00 PM
- Branded Legacy, Inc. Announces Provisional Patent Filing by BioLegacy for Disruptive Air-Driven Intranasal Platform Targeting Multi-Billion-Dollar Global Therapeutics Market • GlobeNewswire Inc. • 09/30/2025 12:30:00 PM
- Branded Legacy Inc. Unveils Cutting-Edge GMP Facility to Accelerate Life-Saving Inhaled Naloxone Development • GlobeNewswire Inc. • 09/23/2025 02:44:55 PM
- Branded Legacy Inc. Unveils Cutting-Edge GMP Facility to Accelerate Life-Saving Inhaled Naloxone Development • InvestorsHub NewsWire • 09/23/2025 01:40:59 PM
- Branded Legacy, Inc. Expands Capabilities with Acquisition of State-of-the-Art GMP Facility in Vancouver • InvestorsHub NewsWire • 09/04/2025 12:30:00 PM
- Branded Legacy, Inc. Forms Strategic Partnership with Stanford University's Dr. Eran Bendavid to Advance Addiction Solutions • InvestorsHub NewsWire • 08/22/2025 05:39:40 PM
- Branded Legacy, Inc. Partners with McMaster University: Revolutionizing Addiction Treatment Through Cutting-Edge Clinical Research and Regulatory Pathways • InvestorsHub NewsWire • 08/19/2025 12:39:04 PM
- Branded Legacy, Inc. Finalizes Transformative Acquisition of Bio Legacy Evaluative Group (f/k/a Menlo Health), Unlocking Explosive Growth Potential in Biotech and Drug Delivery • InvestorsHub NewsWire • 08/12/2025 12:30:00 PM
- Branded Legacy, Inc. Signs Letter of Intent to Acquire Bio-Legacy Evaluative Group, Advancing Innovations in Intranasal Drug Delivery • InvestorsHub NewsWire • 07/29/2025 12:30:00 PM
- Branded Legacy Inc. Announces Leadership Transition and Pending Merger with Innovative Addiction Therapeutics Company Projecting $40 Million in First-Year Revenue • InvestorsHub NewsWire • 07/14/2025 05:23:12 PM
